DNA Shed From Colon Cancers Into Bloodstream Guide Chemotherapy

ADN vertido de cánceres de colon al torrente sanguíneo guía la quimioterapia

Un nuevo estudio de investigación demostró que el ADN tumoral circulante (ctDNA), material genético eliminado de los tumores al torrente sanguíneo, puede identificar a los pacientes con cáncer de colon en etapa II que pueden beneficiarse más de la quimioterapia después de la cirugía. Leer más sobre este estudio y cómo se beneficiarán los pacientes.

VER TODAS LAS NOTICIAS

Mensajes recientes

New Technology: MRI-guided Focused Ultrasound for Prostate Cancer Advances in Breast Cancer Treatment: Insights from Medical Oncologist Jenni Sheng Early Immunotherapy Shows Promising Results in Advanced Basal Cell Carcinoma New NIH-Funded Johns Hopkins Medicine Study Finds High-Risk Individuals Who Have Mild Dilatation of the Pancreatic Duct Have Increased Risk for Pancreatic Cancer Lung Cancer Symptoms Doctors Say Women Should Never Ignore and the Screening Most Skip Targeted Radiation During Surgery Reduces Pancreatic Cancer Recurrence Colorectal Cancer Is Becoming More Common In Young People. Here Are The Signs. Johns Hopkins-Led Study Finds Drugs Approved for Treating Pain Also Reduce Bone Cancer Growth DNA Shed by Colon Cancers May Help Oncologists Personalize Postsurgical Treatment